CL
54
-4
NKE
48
6
PNC
80
4
WYNN
36
2
MMM
63
6
MNST
47
-3
NRG
59
2
PGR
55
6
PVH
47
4
CSCO
63
-4
ALL
57
9
BEN
52
2
PSA
51
5
FFIV
55
5
JPM
69
2
HPQ
39
-2
CTAS
40
6
BAX
48
4
WM
51
4
GIS
57
3
CL
54
-4
NKE
48
6
PNC
80
4
WYNN
36
2
MMM
63
6
MNST
47
-3
NRG
59
2
PGR
55
6
PVH
47
4
CSCO
63
-4
ALL
57
9
BEN
52
2
PSA
51
5
FFIV
55
5
JPM
69
2
HPQ
39
-2
CTAS
40
6
BAX
48
4
WM
51
4
GIS
57
3
Financhill
Back

TECSYS, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
45

TCS.TO
TECSYS, Inc.

Last Price:
$32.06
Seasonality Move:
12.77%
Sell
33

NKTR
Nektar Therapeutics

Last Price:
$53.92
Seasonality Move:
11.58%
Sell
45
TECSYS, Inc. (TCS.TO) is a Sell

Is TECSYS, Inc. a Buy, Sell or Hold?

  • The current TECSYS, Inc. [TCS.TO] share price is $33.00. The Score for TCS.TO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • TCS.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $51.12. The Score for NKTR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TCS.TO Stock Price Chart

What is TECSYS, Inc.'s stock price today?

  • The TECSYS, Inc. share price today is $33.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCS.TO is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $51.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.

TCS.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 40.9 Sell
Chaikin Money Flow: -16704 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.33 - 35.33) Sell
Bollinger Bands (100): (33.86 - 36.86) Sell

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 39.75 Sell
Chaikin Money Flow: -893008 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.73 - 61.07) Sell
Bollinger Bands (100): (32.3 - 62.42) Buy

TCS.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.56 Sell
20-day SMA: 34.25 Sell
50-day SMA: 34.59 Sell
200-day SMA: 38.06 Sell
8-day EMA: 33.53 Sell
20-day EMA: 34.08 Sell
50-day EMA: 34.63 Sell
200-day EMA: 37.24 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.44 Sell
20-day SMA: 58.08 Sell
50-day SMA: 58.52 Sell
200-day SMA: 30.43 Buy
8-day EMA: 56.58 Sell
20-day EMA: 57.71 Sell
50-day EMA: 55.82 Sell
200-day EMA: 37.69 Buy

TECSYS, Inc. Earnings Growth & TCS.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and a decrease next year of $0.02 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

TECSYS, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):